Our results suggest that ACSL3 and EPAS1 genes and related pathways are a method of iron death parallel to apoptosis, which is a potential therapeutic target for the treatment of drug-resistant PCa, and also an indicator for predicting the occurrence of BCR. This evidence concerns the gene EPAS1 and posterior cortical atrophy.